MedTrace Logo

Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer

NCT03564171 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2023-04-12

No results posted yet for this study

Summary

To assess recruitment rate, attrition, compliance with weekly exercise, smoking cessation, and quality of life with a multimodal prehabilitation protocol for women with breast cancer undergoing neo-adjuvant chemotherapy for breast cancer.

Conditions

  • Breast Cancer
  • Rehabilitation
  • Neoadjuvant Therapy
  • Feasibility Studies

Interventions

COMBINATION_PRODUCT

Prehabilitation

stress counseling, exercise, nutritional counseling, smoking cessation counseling

Sponsors & Collaborators

  • University Health Network, Toronto

    collaborator OTHER

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Frances Wright, MD · Sunnybrook Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-18
Primary Completion
2023-03-31
Completion
2023-03-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03564171 on ClinicalTrials.gov